Cue Biopharma

Cue Biopharma Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 47
Employees
  • Stock Symbol
  • CUE
Stock Symbol
  • Share Price
  • $23.54
  • (As of Wednesday Closing)

Cue Biopharma General Information

Description

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers.

Contact Information

Formerly Known As
ImaGen Biopharma
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Stock Exchange
NAS
Primary Office
  • 675 West Kendall Street
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

Cue Biopharma Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cue Biopharma Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$23.54 $22.70 $6.54 - $31.69 $670M 28.4M 382K -$1.62

Cue Biopharma Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 323,303 340,697 55,445
Revenue 3,988 3,458 1,143 0
EBITDA (33,123) (31,540) (37,771) (22,814)
Net Income (38,247) (36,699) (38,980) (23,234)
Total Assets 60,649 71,605 45,363 66,954
Total Debt 4,709 5,796 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cue Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cue Biopharma‘s full profile, request access.

Request a free trial

Cue Biopharma Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Zymeworks Formerly VC-backed Vancouver, Canada 000 00000 00000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
0000000 0000000000 Formerly VC-backed Heidelberg, Germany 000 00000 00000000000 00000
000000000 00000000 Formerly VC-backed Tarrytown, NY 0000 00000 00000000000 00000

Cue Biopharma Executive Team (9)

Name Title Board Seat Contact Info
Daniel Passeri JD Chief Executive Officer & Board Member
Anish Suri Chief Scientific Officer & Senior Vice President
Colin Sandercock General Counsel, Legal & Secretary, Administration
Kenneth Pienta Chief Medical Officer

5 Former Executives

Cue Biopharma Board Members (10)

To view Cue Biopharma‘s full board member team, request access »
Name Representing Role Since
00000 00000000 00.0 Self Board Member 000 0000
0000000 00000000000000 Cue Biopharma Board Member 000 0000
00000 00000 00 Cue Biopharma Board Member 000 0000
0000000 0000 00.0 Self Board Member 000 0000
000000 0000000 00 Cue Biopharma Chief Executive Officer & Board Member 000 0000

3 Former Board Members

Ready to get started?

Request a free trial